These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 15815752)

  • 41. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
    Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
    Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients.
    Boffa GM; Zaninotto M; Bacchiega E; Nalli C; Forni M; Tiso E; Cacciavillani L; Razzolini R; Plebani M
    Ital Heart J; 2005 Feb; 6(2):125-32. PubMed ID: 15819505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Plasma cardiac natriuretic peptide as a biological marker of recurrence of atrial fibrillation in elderly people].
    Mabuchi N; Tsutamoto T; Maeda K; Masahiko K
    Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):535-40. PubMed ID: 11031826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure.
    Frasure-Smith N; Lespérance F; Habra M; Talajic M; Khairy P; Dorian P; Roy D;
    Circulation; 2009 Jul; 120(2):134-40, 3p following 140. PubMed ID: 19564557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.
    Shimamoto K; Kusumoto M; Sakai R; Watanabe H; Ihara S; Koike N; Kawana M
    Can J Cardiol; 2007 Mar; 23(4):295-300. PubMed ID: 17380223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
    Feola M; Menardi E; Ribichini F; Vado A; Deorsola A; Ferrero V; Visconti G; Milanese U; Uslenghi E
    Med Sci Monit; 2003 Aug; 9(8):CR341-5. PubMed ID: 12942029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
    Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D
    Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Hillege HL; Van Veldhuisen DJ
    Int J Cardiol; 2006 Apr; 109(1):95-100. PubMed ID: 15993501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study.
    Shibazaki K; Kimura K; Okada Y; Iguchi Y; Terasawa Y; Aoki J
    J Neurol Sci; 2009 Jun; 281(1-2):55-7. PubMed ID: 19321180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma level of atrial natriuretic peptide as an indicator of increased cardiac load in uremic patients.
    Tikkanen I; Metsärinne K; Grönhagen-Riska C; Fyhrquist F
    Clin Nephrol; 1990 Oct; 34(4):167-72. PubMed ID: 2147876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response.
    Boriani G; Regoli F; Saporito D; Martignani C; Toselli T; Biffi M; Francolini G; Diemberger I; Bacchi L; Rapezzi C; Ferrari R; Branzi A
    Peptides; 2006 Jul; 27(7):1776-86. PubMed ID: 16621149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Plasma atrial natriuretic peptide levels and their clinical importance in infant with pneumonia associated with congestive heart failure].
    Guo Z
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):130-2, 10. PubMed ID: 2163735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of exercise training on chromogranin A and relationship to N-ANP and inflammatory cytokines in patients with chronic heart failure.
    Larsen AI; Helle KB; Christensen M; Kvaløy JT; Aarsland T; Dickstein K
    Int J Cardiol; 2008 Jun; 127(1):117-20. PubMed ID: 17586073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of naloxone on plasma levels of atrial natriuretic factor and noradrenaline during water load in moderate heart failure].
    Tarsi G; Paradossi U; Tartuferi L; Schipani A; Palmisano D; De Iasio R; Carboni L; Fontana F; Bernardi P
    G Ital Cardiol; 1996 Aug; 26(8):879-85. PubMed ID: 9005170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
    Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
    Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
    Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.